Suppr超能文献

比较七种肝分配模型,以评估其在肝移植等待名单上的患者的生存获益。

Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list.

机构信息

Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD 21201-1596, USA.

出版信息

Transpl Int. 2012 Apr;25(4):409-15. doi: 10.1111/j.1432-2277.2012.01431.x. Epub 2012 Feb 2.

Abstract

The patients with end-stage liver disease (ESLD) on the liver transplant waiting list are prioritized for transplant based on the model for end-stage liver disease (MELD) score. We developed and used an innovative approach to compare MELD to six proposed alternatives with respect to waiting list mortality. Our analysis was based on United Network for Organ Sharing data of patients with ESLD on the waiting list between January 2006 and June 2009. We compared six allocation models to MELD. Two models were based on reweighting the variables used by MELD: an "updated" MELD, and ReFit MELD. Four models also included serum sodium: MESO, MeldNa, UKELD, and ReFit MELDNa. We estimated that UKELD and the updated MELD would result in significantly fewer lives saved. There were no significant differences between the other models. Our new approach can supplement standard methods to provide insight into the relative performance of liver allocation models in reducing waiting list mortality. Our analysis suggests that UKELD and the updated MELD score would not be optimal for reducing waiting list mortality in the United States.

摘要

终末期肝病(ESLD)患者根据终末期肝病模型(MELD)评分在肝移植等待名单上优先考虑移植。我们开发并使用了一种创新方法,比较了 MELD 与其他六种替代方案在等待名单死亡率方面的表现。我们的分析基于 2006 年 1 月至 2009 年 6 月期间在等待名单上的 ESLD 患者的美国器官共享网络数据。我们将六种分配模型与 MELD 进行了比较。两种模型基于对 MELD 所使用变量的重新加权:“更新的”MELD 和 ReFit MELD。另外四种模型也包括血清钠:MESO、MeldNa、UKELD 和 ReFit MELDNa。我们估计 UKELD 和更新的 MELD 将导致显著较少的生命得到挽救。其他模型之间没有显著差异。我们的新方法可以补充标准方法,为评估肝脏分配模型在降低等待名单死亡率方面的相对表现提供了深入了解。我们的分析表明,UKELD 和更新的 MELD 评分在美国不是降低等待名单死亡率的最佳选择。

相似文献

2
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.MELD 3.0:适应新时代的终末期肝病模型。
Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050. Epub 2021 Sep 3.
3
Re-weighting the model for end-stage liver disease score components.重新权衡终末期肝病评分组件的模型。
Gastroenterology. 2008 Nov;135(5):1575-81. doi: 10.1053/j.gastro.2008.08.004. Epub 2008 Aug 15.

引用本文的文献

3
Predictive Capacity of Risk Models in Liver Transplantation.肝移植中风险模型的预测能力
Transplant Direct. 2019 May 22;5(6):e457. doi: 10.1097/TXD.0000000000000896. eCollection 2019 Jun.
5
Model for End-stage Liver Disease.终末期肝病模型
J Clin Exp Hepatol. 2013 Mar;3(1):50-60. doi: 10.1016/j.jceh.2012.11.002. Epub 2012 Dec 1.
6
A novel prognostic score for acute-on-chronic hepatitis B liver failure.一种用于慢性乙型肝炎急性肝衰竭的新型预后评分系统。
J Huazhong Univ Sci Technolog Med Sci. 2015 Feb;35(1):87-92. doi: 10.1007/s11596-015-1394-5. Epub 2015 Feb 12.
7
Liver transplantation: fifty years of experience.肝移植:五十年的经验
World J Gastroenterol. 2014 May 14;20(18):5363-74. doi: 10.3748/wjg.v20.i18.5363.

本文引用的文献

6
Survival benefit-based deceased-donor liver allocation.基于生存获益的脑死亡供体肝脏分配
Am J Transplant. 2009 Apr;9(4 Pt 2):970-81. doi: 10.1111/j.1600-6143.2009.02571.x.
7
Re-weighting the model for end-stage liver disease score components.重新权衡终末期肝病评分组件的模型。
Gastroenterology. 2008 Nov;135(5):1575-81. doi: 10.1053/j.gastro.2008.08.004. Epub 2008 Aug 15.
9
The Monte Carlo method.蒙特卡罗方法。
J Am Stat Assoc. 1949 Sep;44(247):335-41. doi: 10.1080/01621459.1949.10483310.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验